Sentinel Oncology present at the ‘Fragile X Syndrome: Innovative Approaches to Finding a Cure’ event
David Walker, Sentinel Oncology Director of Chemistry, has been invited to join over 30 leading experts to speak at the event ‘Fragile X Syndrome: Innovative Approaches to Finding a Cure’ which will be held on July 22nd, 2022 on Fragile X Syndrome Awareness Day.
The event is co-hosted by WuXi AppTec and the FRAXA Research Foundation and aims to shape new thinking in advancing breakthroughs for rare disease patients and to raise public awareness.
David was invited to give his insights into what led Sentinel Oncology to work on Fragile X Syndrome, what approach Sentinel is taking, and how our approach is differentiated from others in the field.
